Theruptor Novo dressing for an infected diabetic foot ulcer: a case study


  • B. Pavan Department of Podiatry, Karnataka Institute of Endocrinology and Research, Bengaluru, Karnataka, India



Diabetes mellitus, Diabetic foot ulcer, Theruptor Novo


In diabetes mellitus (DM) patients with peripheral neuropathy, the diabetic foot infection (DFI) often begins with a small wound that patients may not easily detect and then progresses to a more complex wound. Diabetic foot ulcer (DFU) is estimated to occur in approximately in 25% of individuals with diabetes in India. The bacterial infection is one of the important cause for the chronicity of DFU and are accountable for the high medical costs as well as affecting patients’ quality of life significantly. Preventing DFU secondary infections is an important function of wound dressing. There are many wound dressings available for DFU, and choosing the right dressing is one of the important parameter in the management and ultimately preventing the limb amputation. In this case, the patient presented with non-healing infected DFU and we used Theruptor Novo dressings for the wound management. The Theruptor Novo dressing was efficient in exudate management and preventing secondary infection which helped in accelerated DFU healing.


Metrics Loading ...


Sun H, Saeedi P, Karuranga S, Pinkepank M, Ogurtsova K, Duncan BB et al. IDF Diabetes Atlas: Global, regional and country level diabetes prevalence estimates for 2021 and projections for 2045. Diabetes Res Clin Pract 2022;183:109119.

Hills AP, Arena R, Khunti K, Yajnik CS, Jayawardena R, Henry CJ et al. Epidemiology and determinants of type 2 diabetes in south Asia. Lancet Diabetes Endocrinol. 2018;6:966 78.

International Diabetes Federation. Diabetes Atlas. 2006. Available at: idfawp/resource-files/2021/07/IDF_Atlas_10th_ Edition_2021.pdf Accessed on 13 September, 2023.

Lipsky BA. Anthony RB, Paul BC, James CP, Edgar JGP, David GA et al. 2012 Infectious Diseases Society of America clinical practice guideline for the diagnosis and treatment of diabetic foot infections. Clin Infect Dis. 2012;54(12):e132-73.

Kale DS, Karande GS, Datkhile KD. Diabetic foot ulcer in India: Aetiological trends and bacterial diversity. Indian J Endocr Metab 2023;27:107 14.

Margolis DJ, Malay DS, Hoffstad OJ, Charles EL, Thomas MC, Karla LN et al. Incidence of diabetic foot ulcer and lower extremity amputation among medicare beneficiaries, 2006 to 2008. Rockville (MD): Agency for Healthcare Research and Quality (US). 2011.

Wukich DK, Raspovic KM, Suder NC. Patients with diabetic foot disease fear major lower‑extremity amputation more than death. Foot Ankle Spec. 2018;11(1):17-21.

Sadeghpour Heravi F, Zakrzewski M, Vickery K, G Armstrong D, Hu H. Bacterial Diversity of Diabetic Foot Ulcers: Current Status and Future Prospectives. J Clin Med. 2019;8(11):1935.

Oliver TI, Mutluoglu M. Diabetic Foot Ulcer. In: StatPearls. Treasure Island (FL): StatPearls Publishing. 2023.

Benbow M. Diabetic foot ulcers. J Community Nursing. 2012;26(5).

Price PE, Fagervik-Morton H, Mudge EJ. Dressing-related pain in patients with chronic wounds: an international patient perspective. Int Wound J. 2008;5(2):159-71.

Richie G, Santosh M, Bhagavan KR, Moharana AK, Michael R, Deepak TS, Antimicrobial properties of Theruptor 3D-hydrocellular wound dressing: An in vitro study, Int J Surg Open. 2022;46:100528.






Case Reports